ATE241343T1 - Verfahren zur herstellung von transdermalen therapeutischen systemen unter verwendung von basischen alkalimetallsalzen zur umwandlung von wirkstoffsalzen in die freien basen - Google Patents

Verfahren zur herstellung von transdermalen therapeutischen systemen unter verwendung von basischen alkalimetallsalzen zur umwandlung von wirkstoffsalzen in die freien basen

Info

Publication number
ATE241343T1
ATE241343T1 AT99917831T AT99917831T ATE241343T1 AT E241343 T1 ATE241343 T1 AT E241343T1 AT 99917831 T AT99917831 T AT 99917831T AT 99917831 T AT99917831 T AT 99917831T AT E241343 T1 ATE241343 T1 AT E241343T1
Authority
AT
Austria
Prior art keywords
salts
alkaline metal
basic alkaline
transdermal therapeutic
free bases
Prior art date
Application number
AT99917831T
Other languages
German (de)
English (en)
Inventor
Walter Mueller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of ATE241343T1 publication Critical patent/ATE241343T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99917831T 1998-03-30 1999-03-20 Verfahren zur herstellung von transdermalen therapeutischen systemen unter verwendung von basischen alkalimetallsalzen zur umwandlung von wirkstoffsalzen in die freien basen ATE241343T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814083A DE19814083C2 (de) 1998-03-30 1998-03-30 Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen
PCT/EP1999/001876 WO1999049844A2 (de) 1998-03-30 1999-03-20 Verfahren zur herstellung von transdermalen therapeutischen systemen unter verwendung von basischen alkalimetallsalzen zur umwandlung von wirkstoffsalzen in die freien basen

Publications (1)

Publication Number Publication Date
ATE241343T1 true ATE241343T1 (de) 2003-06-15

Family

ID=7862903

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99917831T ATE241343T1 (de) 1998-03-30 1999-03-20 Verfahren zur herstellung von transdermalen therapeutischen systemen unter verwendung von basischen alkalimetallsalzen zur umwandlung von wirkstoffsalzen in die freien basen

Country Status (11)

Country Link
US (1) US6620429B1 (https=)
EP (1) EP1067916B1 (https=)
JP (1) JP4240813B2 (https=)
KR (1) KR100550887B1 (https=)
AT (1) ATE241343T1 (https=)
AU (1) AU758291B2 (https=)
CA (1) CA2326660C (https=)
DE (2) DE19814083C2 (https=)
ES (1) ES2201705T3 (https=)
NO (1) NO329144B1 (https=)
WO (1) WO1999049844A2 (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6562369B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
US6582724B2 (en) 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
US6645520B2 (en) 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
US6586000B2 (en) 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US6562368B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
US6562370B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
US6565879B1 (en) 1999-12-16 2003-05-20 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
US6558695B2 (en) 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10103860B4 (de) * 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
DE10234673B4 (de) 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
EP1386604A1 (en) * 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system
US8246980B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
EP1386605A1 (en) * 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system for the administration of rotigotine
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
ATE295726T1 (de) * 2002-12-02 2005-06-15 Sanol Arznei Schwarz Gmbh Verabreichung von rotigotine zur behandlung der parkinson'schen krankheit durch iontophorese
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
US20040214215A1 (en) * 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
US20050196418A1 (en) * 2004-03-04 2005-09-08 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
SI2215072T1 (sl) 2007-11-28 2015-10-30 Ucb Pharma Gmbh Polimorfna oblika rotigotina
EP2258369B1 (en) * 2008-02-27 2015-04-08 Hisamitsu Pharmaceutical Co., Inc. Medicated patch
JP5546013B2 (ja) * 2008-02-27 2014-07-09 久光製薬株式会社 貼付剤及び包装体
DE102008013701A1 (de) 2008-03-11 2009-09-17 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit stabilisierter Membran
US8815261B2 (en) 2009-06-19 2014-08-26 Medrx Co., Ltd. Composition for external application comprising aripiprazole and organic acid as active ingredients
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
KR102013477B1 (ko) 2012-07-26 2019-08-22 히사미쓰 세이야꾸 가부시키가이샤 첩부제
US11123305B2 (en) 2012-07-26 2021-09-21 Hisamitsu Pharmaceutical Co., Inc. Patch
WO2018115010A1 (en) 2016-12-20 2018-06-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
ES2769286T3 (es) 2016-12-20 2020-06-25 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina
ES2881783T3 (es) 2017-06-26 2021-11-30 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona
CA3101420A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
CN112533593A (zh) 2018-06-20 2021-03-19 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统
CN113677343B (zh) * 2019-03-19 2023-11-24 耐贝医药株式会社 生物体对药物的吸收性优异且化学稳定性也优异的医药组合物
DE102020207642A1 (de) * 2020-06-19 2021-12-23 Lts Lohmann Therapie-Systeme Ag Verfahren zur herstellung von asenapin in form seiner freien base

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3643987A1 (de) 1986-12-22 1988-06-23 Lohmann Therapie Syst Lts Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4837027A (en) * 1987-11-09 1989-06-06 Alza Corporation Transdermal drug delivery device
DE3905051A1 (de) * 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (i)
DE3905050A1 (de) * 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii)
EP0593807A1 (en) 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation

Also Published As

Publication number Publication date
JP2002509874A (ja) 2002-04-02
NO20004926D0 (no) 2000-09-29
WO1999049844A3 (de) 1999-11-25
CA2326660C (en) 2005-11-29
KR100550887B1 (ko) 2006-02-10
ES2201705T3 (es) 2004-03-16
AU3597499A (en) 1999-10-18
DE19814083A1 (de) 1999-10-14
KR20010072561A (ko) 2001-07-31
DE59905750D1 (de) 2003-07-03
AU758291B2 (en) 2003-03-20
NO20004926L (no) 2000-11-22
JP4240813B2 (ja) 2009-03-18
NO329144B1 (no) 2010-08-30
CA2326660A1 (en) 1999-10-07
DE19814083C2 (de) 2002-02-07
WO1999049844A2 (de) 1999-10-07
US6620429B1 (en) 2003-09-16
EP1067916A2 (de) 2001-01-17
EP1067916B1 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
ATE241343T1 (de) Verfahren zur herstellung von transdermalen therapeutischen systemen unter verwendung von basischen alkalimetallsalzen zur umwandlung von wirkstoffsalzen in die freien basen
ATE195715T1 (de) Verfahren zur herstellung von produkten, die bisalze der ameisensäure enthalten
EP1180371A4 (en) ACTIVE SUBSTANCES FOR PROMOTING A MEMBRANE BASED ON THE SKIN, ACTIVE SUBSTANCES FOR PROMOTING THE TRAINING OF ARTIFICIAL SKIN AND METHOD FOR PRODUCING ARTIFICIAL SKIN
DK1185520T3 (da) Fremgangsmåde til fremstilling af thiazolidin
DE68904918D1 (de) Einstufiges verfahren zur herstellung von methyl-tert.butylether.
DE69710051D1 (de) Auflösungsverfahren von threo-methylphenidate
DE69808086D1 (de) Ein verfahren zur herstellung von 1,4,7,10-tetraazacyclododecan-1,4,7-triessigsäure und deren derivaten
DE68905350D1 (de) Einstufiges verfahren zur herstellung von methyl-tert.butylether.
DE69931493D1 (de) Verfahren zur herstellung von hydroxymethylthiobuttersäure
DE3780760D1 (de) Verfahren zur herstellung von silikonmikrokapseln, geliert durch eine michael-additionsreaktion.
ATE253030T1 (de) Verfahren zur herstellung von 1,1,4,4- tetramethoxybuten-2
ATE192426T1 (de) Verfahren zur herstellung der valproinsäure
ES2046797T3 (es) Produccion de acido glioxilico mediante oxidacion enzimatica de acido glicolico.
ATE281444T1 (de) Verfahren zur herstellung von gamma-butyrolacton
DE50112449D1 (de) Verfahren zur herstellung von 3,3-diarylpropylaminen
DE59701415D1 (de) Verfahren zur herstellung von celluloseformkörpern und die mit diesem verfahren hergestellten formkörper sowie deren verwendung
DE59807664D1 (de) Verfahren zur herstellung von 3-cyano-2,4-dihalogen-5-fluor-benzoesäuren
DE3877324D1 (de) Verfahren zur herstellung von acrylamidomethansulfonsaeure-polymeren.
NO990159D0 (no) FremgangsmÕte for fremstilling av enantiomerisk anrikede N-acylazetidin-2-karboksylsyrer
DE58901283D1 (de) Verfahren zur herstellung eines plattenfoermigen traegers katalytisch wirkender verbindungen.
NZ239435A (en) Conversion of the r(-) isomer of ketoprofen to the s(+) isomer
DE69700236D1 (de) Verfahren zur herstellung von (-)-trans-n-p-fluorbenzoylmethyl-4-(p-fluorphenyl)-3-[[3,4-(methylendioxy)phenoxy]methyl]-piperidin
DE50001638D1 (de) Verfahren zur herstellung von 4,6-dichlorpyrimidin
DE68905413D1 (de) Verfahren zur herstellung von alkalimetallsalz von 2,3,6,7-naphthalintetracarbonsaeure.
ATE260883T1 (de) Verfahren zur herstellung von atropasäureethylester

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee